ClinicalTrials.govpublic full text
Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial
covid19, inactivated vaccine, phase iib, severe acute respiratory syndrome, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858466
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.